Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Miniaturization of CMOS.

Radamson HH, He X, Zhang Q, Liu J, Cui H, Xiang J, Kong Z, Xiong W, Li J, Gao J, Yang H, Gu S, Zhao X, Du Y, Yu J, Wang G.

Micromachines (Basel). 2019 Apr 30;10(5). pii: E293. doi: 10.3390/mi10050293. Review.

2.

1H NMR-based metabolomic study of metabolic profiling for the urine of kidney stone patients.

Duan X, Zhang T, Ou L, Kong Z, Wu W, Zeng G.

Urolithiasis. 2019 Apr 4. doi: 10.1007/s00240-019-01132-2. [Epub ahead of print]

PMID:
30949730
3.

Peroxisome proliferator-activated receptor γ modulates renal crystal retention associated with high oxalate concentration by regulating tubular epithelial cellular transdifferentiation.

Li S, Lan Y, Wu W, Duan X, Kong Z, Wu W, Zeng G.

J Cell Physiol. 2019 Mar;234(3):2837-2850. doi: 10.1002/jcp.27102. Epub 2018 Oct 14.

PMID:
30317563
4.

β-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth in vitro and in vivo.

Kong Z, Deng T, Zhang M, Zhao Z, Liu Y, Luo L, Cai C, Wu W, Duan X.

Cancer Sci. 2018 Jun;109(6):1834-1842. doi: 10.1111/cas.13619. Epub 2018 May 26.

5.

Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney.

Duan X, Kong Z, Mai X, Lan Y, Liu Y, Yang Z, Zhao Z, Deng T, Zeng T, Cai C, Li S, Zhong W, Wu W, Zeng G.

Redox Biol. 2018 Jun;16:414-425. doi: 10.1016/j.redox.2018.03.019. Epub 2018 Apr 2.

6.

Bias-Exchange Metadynamics Simulation of Membrane Permeation of 20 Amino Acids.

Cao Z, Bian Y, Hu G, Zhao L, Kong Z, Yang Y, Wang J, Zhou Y.

Int J Mol Sci. 2018 Mar 16;19(3). pii: E885. doi: 10.3390/ijms19030885.

7.

PARP1-siRNA suppresses human prostate cancer cell growth and progression.

Lai Y, Kong Z, Zeng T, Xu S, Duan X, Li S, Cai C, Zhao Z, Wu W.

Oncol Rep. 2018 Apr;39(4):1901-1909. doi: 10.3892/or.2018.6238. Epub 2018 Jan 26.

PMID:
29393407
8.

Does green tea consumption increase urinary oxalate excretion? Results of a prospective trial in healthy men.

Chen K, Chen D, Lan C, Liang X, Zeng T, Huang J, Duan X, Kong Z, Li S, Tiselius HG, Gurioli A, Lu X, Zeng G, Wu W.

Int Urol Nephrol. 2018 Jan;50(1):29-33. doi: 10.1007/s11255-017-1720-x. Epub 2017 Oct 19.

PMID:
29052087
9.

Prevalence of kidney stones in China: an ultrasonography based cross-sectional study.

Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, Long Y, Ma J, Li Y, Wan SP, Wu W, Liu Y, Cui Z, Zhao Z, Qin J, Zeng T, Liu Y, Duan X, Mai X, Yang Z, Kong Z, Zhang T, Cai C, Shao Y, Yue Z, Li S, Ding J, Tang S, Ye Z.

BJU Int. 2017 Jul;120(1):109-116. doi: 10.1111/bju.13828. Epub 2017 Mar 21.

10.

L-Carnitine Protects Renal Tubular Cells Against Calcium Oxalate Monohydrate Crystals Adhesion Through Preventing Cells From Dedifferentiation.

Li S, Wu W, Wu W, Duan X, Kong Z, Zeng G.

Kidney Blood Press Res. 2016;41(5):582-592. Epub 2016 Aug 24.

11.

β-arrestin1 promotes epithelial-mesenchymal transition via modulating GSK-3β/β-catenin pathway in prostate cancer cells.

Duan X, Zhang T, Kong Z, Mai X, Lan C, Chen D, Liu Y, Zeng Z, Cai C, Deng T, Wu W, Zeng G.

Biochem Biophys Res Commun. 2016 Oct 14;479(2):204-210. doi: 10.1016/j.bbrc.2016.09.039. Epub 2016 Sep 9.

PMID:
27620488
12.

Whole-Genome Sequencing for the Investigation of a Hospital Outbreak of MRSA in China.

Kong Z, Zhao P, Liu H, Yu X, Qin Y, Su Z, Wang S, Xu H, Chen J.

PLoS One. 2016 Mar 7;11(3):e0149844. doi: 10.1371/journal.pone.0149844. eCollection 2016.

13.

siRNA Targeting the 2Apro Genomic Region Prevents Enterovirus 71 Replication In Vitro.

Liu H, Qin Y, Kong Z, Shao Q, Su Z, Wang S, Chen J.

PLoS One. 2016 Feb 17;11(2):e0149470. doi: 10.1371/journal.pone.0149470. eCollection 2016.

14.

β-Arrestin2 Contributes to Cell Viability and Proliferation via the Down-Regulation of FOXO1 in Castration-Resistant Prostate Cancer.

Duan X, Kong Z, Liu Y, Zeng Z, Li S, Wu W, Ji W, Yang B, Zhao Z, Zeng G.

J Cell Physiol. 2015 Oct;230(10):2371-81. doi: 10.1002/jcp.24963.

PMID:
25752515
15.

Expression of PARP-1 and its active polymer PAR in prostate cancer and benign prostatic hyperplasia in Chinese patients.

Wu W, Zhu H, Liang Y, Kong Z, Duan X, Li S, Zhao Z, Yang D, Zeng G.

Int Urol Nephrol. 2014 Jul;46(7):1345-9. doi: 10.1007/s11255-014-0642-0. Epub 2014 Jan 17.

PMID:
24436031
16.

Inhibition of PARP1 by small interfering RNA enhances docetaxel activity against human prostate cancer PC3 cells.

Wu W, Kong Z, Duan X, Zhu H, Li S, Zeng S, Liang Y, Iliakis G, Gui Z, Yang D.

Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):127-32. doi: 10.1016/j.bbrc.2013.11.027. Epub 2013 Nov 15.

PMID:
24239883

Supplemental Content

Loading ...
Support Center